Brian G. Atwood

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Brian G. Atwood

Form 4 holding Director

CERO THERAPEUTICS HOLDINGS, INC.

Security class
Warrant to Purchase Shares of Common Stock
Shares / value
306,120
Estimated value
$599,965
Report date
07 Feb 2025
Price
$1.96
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CERO THERAPEUTICS HOLDINGS, INC.

Security class
Warrant to Purchase Shares of Common Stock
Shares / value
204,080
Estimated value
$399,976
Report date
07 Feb 2025
Price
$1.96
Ownership
By GVN, LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CERO THERAPEUTICS HOLDINGS, INC.

Security class
Pre-Funded Warrant
Shares / value
204,080
Estimated value
$20
Report date
31 Mar 2025
Price
$0.000100
Ownership
By GVN, LLC
Underlying class
Common Stock
Underlying amount
204,080
Form 4 holding Director

CERO THERAPEUTICS HOLDINGS, INC.

Security class
Pre-Funded Warrant
Shares / value
11,660
Estimated value
$1
Report date
31 Mar 2025
Price
$0.000100
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Clovis Oncology, Inc.

Security class
Stock Option (right to buy)
Shares / value
42,223
Estimated value
Report date
10 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Atreca, Inc.

Security class
Stock Option (right to buy)
Shares / value
12,000
Estimated value
Report date
13 Jun 2023
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Brian G. Atwood

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .